COPT Defense Properties (NYSE:CDP – Get Free Report) had its price target increased by research analysts at JPMorgan Chase & Co. from $33.00 to $34.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 7.26% from the company’s previous close.
A number of other research analysts have also recently issued reports on CDP. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $37.00 price objective on shares of COPT Defense Properties in a research note on Wednesday, April 29th. Jefferies Financial Group raised their price objective on COPT Defense Properties from $33.00 to $34.00 and gave the company a “buy” rating in a research note on Tuesday, January 27th. Citigroup raised their price objective on COPT Defense Properties from $29.00 to $34.00 and gave the company a “neutral” rating in a research note on Tuesday, February 10th. Weiss Ratings raised COPT Defense Properties from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday, April 21st. Finally, Evercore reaffirmed an “outperform” rating and set a $38.00 price objective on shares of COPT Defense Properties in a research note on Tuesday, April 28th. Five investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, COPT Defense Properties presently has a consensus rating of “Moderate Buy” and an average price target of $34.50.
Read Our Latest Stock Report on CDP
COPT Defense Properties Price Performance
COPT Defense Properties (NYSE:CDP – Get Free Report) last released its earnings results on Monday, April 27th. The company reported $0.34 EPS for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.34). The firm had revenue of $200.64 million during the quarter, compared to the consensus estimate of $185.10 million. COPT Defense Properties had a net margin of 20.10% and a return on equity of 10.02%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.65 EPS. COPT Defense Properties has set its FY 2026 guidance at 2.730-2.790 EPS and its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts anticipate that COPT Defense Properties will post 2.78 earnings per share for the current year.
Insider Buying and Selling
In other COPT Defense Properties news, Director Philip L. Hawkins sold 5,536 shares of the firm’s stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $32.71, for a total value of $181,082.56. Following the completion of the sale, the director directly owned 15,188 shares in the company, valued at $496,799.48. This trade represents a 26.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 1.66% of the stock is owned by company insiders.
Institutional Trading of COPT Defense Properties
Several institutional investors and hedge funds have recently bought and sold shares of CDP. Norges Bank purchased a new stake in COPT Defense Properties in the fourth quarter worth about $39,685,000. Alliancebernstein L.P. lifted its holdings in shares of COPT Defense Properties by 16.8% during the third quarter. Alliancebernstein L.P. now owns 8,457,373 shares of the company’s stock valued at $245,771,000 after purchasing an additional 1,215,936 shares during the last quarter. GRS Advisors LLC purchased a new position in shares of COPT Defense Properties during the third quarter valued at approximately $28,399,000. Two Sigma Investments LP lifted its holdings in shares of COPT Defense Properties by 289.9% during the third quarter. Two Sigma Investments LP now owns 900,047 shares of the company’s stock valued at $26,155,000 after purchasing an additional 669,181 shares during the last quarter. Finally, Balyasny Asset Management L.P. lifted its holdings in shares of COPT Defense Properties by 51.8% during the fourth quarter. Balyasny Asset Management L.P. now owns 1,896,161 shares of the company’s stock valued at $52,713,000 after purchasing an additional 647,449 shares during the last quarter.
About COPT Defense Properties
COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.
The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.
Featured Stories
- Five stocks we like better than COPT Defense Properties
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for COPT Defense Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COPT Defense Properties and related companies with MarketBeat.com's FREE daily email newsletter.
